CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to revolutionize tuberculosis treatment by developing innovative clinical trial designs for new anti-TB drugs. By utilizing advanced simulation tools and adaptive trial methodologies, the consortium seeks to efficiently evaluate multiple drug regimens and identify the most promising candidates for fut…
Current anti-tuberculosis (TB) drug regimens face serious limitations at times of increasing antimicrobial drug resistance.
Fortunately, for the first time for centuries, several novel anti-TB compounds are available for clinical evaluation.
As the traditional approach to testing these in multiple combination regimens is too slow and inefficient new approaches of clinical phase 2 study designs are required if we are to meet the targets of the WHO EndTB strategy to save the lives of millions into…
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
